Tobramycin Inhaler

Permitted Indications

Only on the advice of a Cystic Fibrosis Specialist prior to continuation in Primary Care for:

1. Second line suppressive therapy for chronic pulmonary infection with Pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis, when Colobreathe is contraindicated, is not tolerated, or has not produced an adequate clinical response.

Wards Stocked